Article ID Journal Published Year Pages File Type
4332770 Brain Research 2006 10 Pages PDF
Abstract

Gamma-aminobutyric acid (GABA) is the main inhibitory neurotransmitter in the vertebrate brain. GABA activates both ionotropic (GABAA) and metabotropic (GABAB) receptors in mammals. Whether non-mammalian vertebrates possess receptors with similar characteristics is not well understood. We used a mammalian GABAB-specific antagonist to determine the pharmacology of putative receptors in the brain of an anuran amphibian, the male bullfrog (Rana catesbeiana). Receptor binding assays with the antagonist [3H]CGP54626 revealed a single class of high affinity binding sites (with a KD of 2.97 nM and a Bmax of 2619 fmol/mg protein). Binding was time- and temperature-dependent, saturable and specific. Specific binding of [3H]CGP54626 was inhibited by several mammalian GABAB receptor agonists and antagonists. The rank order potency of agonists was: GABA = SKF97541 > (R)-Baclofen > 3-APPA. The rank order for antagonists was: CGP54626 = CGP55845 > CGP52432 > CGP35348. The GABAA receptor ligands muscimol and SR95531 had very low affinity for [3H]CGP54626 binding sites, while bicuculline compounds had no affinity. Binding of GABA was positively modulated by CGP7930. Taurine did not allosterically modulate GABA binding but did inhibit [3H]CGP54626 binding in a linear fashion. Bullfrog brain thus possesses binding sites with significant similarity to mammalian GABAB receptors. These receptors differ from mammalian receptors, however, in dissociation kinetics, ligand specificity and allosteric modulation.

Related Topics
Life Sciences Neuroscience Neuroscience (General)
Authors
, ,